- Conditions
- Cellulite of Thighs
- Interventions
- CelluTite
- Device
- Lead sponsor
- InMode MD Ltd.
- Industry
- Eligibility
- 18 Years to 70 Years · Female only
- Enrollment
- 15 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- New York, New York
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 913–936
of 4,796
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Differential Diagnosis, Diagnostic Accuracy
- Interventions
- AI Diagnostic System (AIMD.1)
- Diagnostic Test
- Lead sponsor
- Magic Health Inc. (d.b.a. Nolla Health)
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Breast Carcinoma
- Interventions
- Tamoxifen, Fulvestrant
- Drug
- Lead sponsor
- University of Southern California
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 4 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Stress Urinary Incontinence
- Interventions
- GTx-024, Matching Placebo
- Drug
- Lead sponsor
- GTx
- Industry
- Eligibility
- 18 Years to 80 Years · Female only
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018
- U.S. locations
- 46
- States / cities
- Homewood, Alabama • Mobile, Alabama • Anchorage, Alaska + 43 more
- Conditions
- Paroxysmal Atrial Fibrillation
- Interventions
- Treatment with IntellaNav StablePoint Ablation Catheter
- Device
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Eligibility
- Not listed
- Enrollment
- 321 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 25
- States / cities
- Jonesboro, Arkansas • Orlando, Florida • Sarasota, Florida + 22 more
- Conditions
- Heart Diseases, Heart Transplantation
- Interventions
- Tacrolimus, Cyclosporine, Mycophenolate mofetil, Methylprednisolone, Prednisone
- Drug
- Lead sponsor
- Astellas Pharma Inc
- Industry
- Eligibility
- Not listed
- Enrollment
- 111 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2008
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Anti-aging, Photoaging
- Interventions
- Sunscreen Moisturizer, Gentle Cleansing Lotion, Facial Moisturizer
- Other
- Lead sponsor
- Revision Skincare
- Industry
- Eligibility
- 35 Years to 60 Years · Female only
- Enrollment
- 36 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2023
- U.S. locations
- 1
- States / cities
- Newtown Square, Pennsylvania
- Conditions
- Refractive Errors
- Interventions
- Delefilcon A contact lenses
- Device
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 97 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023
- U.S. locations
- 6
- States / cities
- Tallahassee, Florida • Eden Prairie, Minnesota • Garner, North Carolina + 3 more
- Conditions
- TTR-mediated Amyloidosis
- Interventions
- ALN-TTR02 (patisiran) administered by intravenous (IV) infusion
- Drug
- Lead sponsor
- Alnylam Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 27 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2016
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Doctor Efficiency, Dental Prosthesis Fit
- Interventions
- Navigated Photogrammetry, Standard Photogrammetry
- Device
- Lead sponsor
- X-Nav Technologies, LLC
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 4 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2025
- U.S. locations
- 1
- States / cities
- Washington D.C., District of Columbia
- Conditions
- Back Pain, Low Back Pain
- Interventions
- Usual Care, Early Treatment
- Other
- Lead sponsor
- Intermountain Health Care, Inc.
- Other
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 3
- States / cities
- South Jordan, Utah • Taylorsville, Utah • West Jordan, Utah
- Conditions
- Atopic Dermatitis
- Interventions
- KT-621
- Drug
- Lead sponsor
- Kymera Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 22 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025
- U.S. locations
- 12
- States / cities
- Birmingham, Alabama • Fountain Valley, California • Santa Monica, California + 9 more
- Conditions
- Pain, Breakthrough Cancer Pain
- Interventions
- SSR411298, Placebo (for SSR411298)
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 5 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012
- U.S. locations
- 2
- States / cities
- Flat Rock, North Carolina • Canton, Ohio
- Conditions
- Prostate Cancer
- Interventions
- 18F DCFPyL- Radiopharmaceutica
- Drug
- Lead sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Other
- Eligibility
- 18 Years to 100 Years · Male only
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2020
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Chlamydia Trachomatis, Gonorrhea
- Interventions
- Not listed
- Lead sponsor
- Hologic, Inc.
- Industry
- Eligibility
- 14 Years and older · Female only
- Enrollment
- 1,766 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016 – 2017
- U.S. locations
- 18
- States / cities
- Birmingham, Alabama • New Haven, Connecticut • Miami, Florida + 15 more
- Conditions
- Presbyopia
- Interventions
- Raindrop Near Vision Inlay
- Device
- Lead sponsor
- ReVision Optics, Inc.
- Industry
- Eligibility
- Not listed
- Enrollment
- 13 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 6
- States / cities
- Laguna Hills, California • Orange, California • Bloomington, Minnesota + 2 more
- Conditions
- Dry Eye Disease
- Interventions
- ABBV-444, REFRESH OPTIVE UD
- Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 261 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 20
- States / cities
- Dothan, Alabama • Chandler, Arizona • Azusa, California + 16 more
- Conditions
- Influenza
- Interventions
- Baloxavir Marboxil, Placebo
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 5 Years to 64 Years
- Enrollment
- 4,138 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2024
- U.S. locations
- 43
- States / cities
- Birmingham, Alabama • Pelham, Alabama • Phoenix, Arizona + 32 more
- Conditions
- Malignant Neoplasm
- Interventions
- Quality-of-Life Assessment, Questionnaire Administration
- Other
- Lead sponsor
- University of Southern California
- Other
- Eligibility
- 15 Years to 39 Years
- Enrollment
- 76 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2025
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Bioequivalence
- Interventions
- Reference, Patch location thigh, batch 1, Test, Patch location thigh, batch 2, Reference, Patch location abdomen, batch 1, Test, Patch location abdomen, batch 2
- Drug · Device
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 6 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012
- U.S. locations
- 1
- States / cities
- Gainesville, Florida
- Conditions
- Type 2 Diabetes Mellitus, Diabetic Peripheral Neuropathy
- Interventions
- Exenatide, Glargine
- Drug
- Lead sponsor
- University of Michigan
- Other
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 46 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2014
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
- Conditions
- Lumbar Vertebra Hernia
- Interventions
- SI-6603
- Drug
- Lead sponsor
- Seikagaku Corporation
- Industry
- Eligibility
- 30 Years to 70 Years
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2007
- U.S. locations
- 1
- States / cities
- Encinitas, California
- Conditions
- Osteoarthritis of the Hip
- Interventions
- Anterior Approach / Posterior Approach, Anterior versus Posterior Approach for total hip replacement
- Procedure
- Lead sponsor
- Barrett, William, M.D.
- Individual
- Eligibility
- 20 Years to 75 Years
- Enrollment
- 87 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2017
- U.S. locations
- 1
- States / cities
- Renton, Washington
- Conditions
- Wound
- Interventions
- MolecuLight i:X Imaging Device
- Device
- Lead sponsor
- MolecuLight Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 367 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 14
- States / cities
- Los Angeles, California • Pembroke Pines, Florida • Athens, Georgia + 11 more